Aktiesnakken — Oktober 2010
-
når man renser for pandemic salg, avandia og generisk konkurrence så har de god vækst nedenunder
-
Emerging markets igen, Vaccine god, Good start in US med vores nye oncology products!!
-
bingo
-
consumer health care kører godt
-
nutricational specielt i indien op med over 20%
-
de sælger sku nudler og småkager i indien
-
r&d briefly
-
overall strong....
-
taler lidt om øst og vest. venter lidt på guldkornene
-
venter på onkologi....
-
så kommer Julian...CFo
-
cost of sales margin omkring 26%
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind